Advancing new approaches for cancer treatment

Cancer continues to present major challenges for patients, healthcare systems and society worldwide. Our goal is to develop new treatment options that help an increasing number of patients.

Understanding of the biological mechanisms of cancer is increasing, and research in oncology is advancing rapidly. Orion Pharma develops new cancer drugs and treatments with the aim of improving outcomes for patients.

We are committed to developing better treatments for cancer patients through deeper understanding of disease biology and treatment resistance.

Our focus has been particularly on hormone-mediated cancers such as prostate cancer. Now our goal is to develop new and effective treatments also for solid cancers.

Our research combines molecular and translational science with therapeutic approaches including small molecules, antibodies, antibody-drug conjugates and cell therapies. By improving understanding of tumour biology and mechanisms driving disease progression, we aim to identify new opportunities for more targeted and effective treatments.